Lactate dehydrogenase (LDH) is an essential enzyme found in nearly every living cell. It plays a primary role in energy production, specifically in glycolysis—the process by which cells convert sugar into energy. During glycolysis, LDH facilitates the conversion of pyruvate into lactate, a crucial step when oxygen levels are low, such as during intense exercise or in specific health conditions.
LDH exists in five distinct forms, called isoenzymes (LDH-1 through LDH-5), which are distributed across different tissues like the heart, liver, muscles, and kidneys. Each isoenzyme is associated with specific organs or tissues: for example, LDH-1 is abundant in the heart, while LDH-5 is found in the liver and skeletal muscle. Analyzing these specific isoenzymes can sometimes help pinpoint the location of tissue damage.
Elevated LDH levels in the blood can signal tissue damage or disease, as cells release LDH when they are injured or destroyed. In clinical settings, high LDH levels serve as an important diagnostic tool to help detect and monitor various health conditions, including heart attacks, liver disease, muscle injuries, and certain types of cancer. Elevated LDH levels are also valuable in oncology, as they can indicate tumor progression or a response to treatment, with cancer cells releasing LDH when they die.
Additionally, increased LDH levels can help diagnose infections and inflammatory conditions. For instance, bacterial infections, viral hepatitis, and autoimmune diseases may elevate LDH levels, reflecting the body’s response to these conditions. Chronic diseases, like certain types of anemia (especially hemolytic anemia), are also associated with high LDH, aiding in differentiating between types of anemia and other blood disorders.
Notably, recent research has linked elevated LDH levels with severe cases of COVID-19. In COVID-19 patients, high LDH levels may correlate with significant lung involvement and a greater need for respiratory support, making LDH a useful marker in assessing disease severity.
While LDH levels alone cannot specify the exact location of tissue damage, they serve as a valuable marker when combined with other diagnostic tests. By measuring LDH, healthcare providers gain a comprehensive view of tissue health, disease progression, and potential tissue damage.
References:
- Henry, J.B., Clinical Diagnosis and Management by Laboratory Methods, 21st ed., Saunders, 2007.
- Rifai, N., Horvath, A.R., Wittwer, C.T., Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 6th ed., Elsevier, 2018.
- Apple, F.S., Wu, A.H., "Biomarkers for Acute Cardiovascular Diseases," Biochemical Society Transactions, 2001.
- Burtis, C.A., Ashwood, E.R., Bruns, D.E., Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 7th ed., Saunders, 2014.
- Hoffman, R., Benz, E.J., Silberstein, L.E., Hematology: Basic Principles and Practice, 6th ed., Elsevier, 2012.
- Schmitt, Y., et al., "Lactate dehydrogenase release as a biomarker of cellular death," Biosensors and Bioelectronics, 2019.
- Farhana, A., Lappin, S.L., "Biochemistry, Lactate Dehydrogenase," StatPearls, 2024. Available at: NCBI Bookshelf
- Lactate Dehydrogenase (LDH) Test, MedlinePlus, MedlinePlus LDH Test
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.